Skip to main content
51°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
February 17, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 15, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 15, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
February 14, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
AZN
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
February 14, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
OSTX
ISO-CERT International Certification Office Expands Services for ISO, FDA, and CE Marking
February 14, 2025
Via
Get News
Exposures
Product Safety
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 14, 2025
Via
NewMediaWire
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 14, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
February 14, 2025
Via
The Motley Fool
Exposures
Product Safety
Tickers
VRTX
Bob's Repair AC, Heating and Solar Experts Las Vegas Launches Workforce and Innovation Initiative to Tackle HVAC Changes
February 13, 2025
Via
GetFeatured
Topics
Product Recall
Exposures
Legal
Product Safety
APLT Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 13, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
APLT Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 13, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Why Is Blood Cancer Focused Moleculin Biotech Stock Trading More Than 400% On Thursday?
February 13, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
MBRX
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
February 13, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
February 13, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Tech Entrepreneur Transforms Personal Struggle into Revolutionary AI Platform Called Magai
February 13, 2025
Via
Press Release Distribution Service
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
Legal
Product Safety
BioMedNewsBreaks – RenovoRx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
February 12, 2025
Via
Investor Brand Network
Exposures
Product Safety
Tickers
RNXT
SpringWorks Therapeutics Secures FDA Approval For Second Cancer Drug
February 12, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
SWTX
Reports Reveal New York Magazine, Prohibitionists Collaborated to Create Series Against MDMA Therapy
February 12, 2025
Via
Investor Brand Network
Exposures
Product Safety
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
February 12, 2025
Via
MarketBeat
Exposures
Product Safety
Tickers
HIMS
LFVN
LLY
NVO
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
February 12, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
February 12, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Trapped in addiction: Lebogang is finally free from one of South Africa’s dangerous drug
February 12, 2025
Via
Press Release Distribution Service
Topics
Product Recall
Exposures
Legal
Product Safety
Travere Therapeutics Sparks Retail Frenzy As Stock Hits Over 2-Year High On FDA Approval Plan For Kidney-Disease Drug
February 11, 2025
Via
Stocktwits
Exposures
Product Safety
Tickers
IWM
TVTX
VTI
XBI
APLT SHAREHOLDER ALERT: Applied Therapeutics Investors are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
February 11, 2025
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
APLT SHAREHOLDER ALERT: Applied Therapeutics Investors are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
February 11, 2025
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
APLT
Travere Therapeutics Skyrockets After Reaching FDA Deal For Kidney Disease Drug
February 11, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
TVTX
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes
February 11, 2025
Via
Benzinga
Exposures
Product Safety
Tickers
LIPO
Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
February 11, 2025
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BHVN
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
February 11, 2025
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
AVAI
BBAI
SOUN
TALK
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.